A DTAP-IPV//PRP~T VACCINE: A REVIEW OF 16 YEARS' CLINICAL EXPERIENCE
Owing to their low reactogenicity, confirmed efficacy and availability in combination vaccines, acellular pertussis (aP)-inactivated poliovirus (IPV) combined vaccines are now included in various national immunization programs worldwide. We provide an overview of 16 years of clinical experience with...
Saved in:
Main Authors: | Stanley A. Plotkin (Author), Johannes Liese (Author), Shabir A. Madhi (Author), Esteban Ortiz (Author) |
---|---|
Format: | Book |
Published: |
"Paediatrician" Publishers LLC,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients
by: Andrew Dakin, et al.
Published: (2023) -
Immunogenicity and safety of a DTaP-IPV//PRP~T combination vaccine given with hepatitis B vaccine: a randomized open-label trial
by: Maria Rosario Capeding, et al.
Published: (2008) -
A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
by: Andrea Guerra, et al.
Published: (2024) -
The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019) -
Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months
by: Pope Kosalaraksa, et al.
Published: (2018)